• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Frequent binge drinking associated with lower AMH in African-American women

byMaren ShapiroandLeah Hawkins Bressler, MD, MPH
July 17, 2016
in Chronic Disease, Obstetrics
Reading Time: 3 mins read
Factors contributing to parents providing alcohol sips to adolescents
Share on FacebookShare on Twitter

1. Current, frequent binge drinking was linked to lower levels of the ovarian aging marker anti-Müllerian hormone (AMH) in reproductive-age African-American women.

2. A range of other drinking and smoking patterns were not associated with AMH levels.

Evidence Rating Level: 2 (Good)

Study Rundown: Excessive alcohol consumption and cigarette smoking are common behaviors among women of all ages, but especially those of reproductive age. The negative health impacts of such behaviors are widely recognized, including their effects on fertility. Previous investigations have identified that heavy alcohol consumption negatively impacts in vitro fertilization (IVF) cycle success. Other studies demonstrate that cigarette smoking is a risk factor for both short and long-term infertility. Anti-Müllerian hormone is released by preantral ovarian follicles and is a validated marker of ovarian reserve in women. To date, no studies have assessed the impact of smoking and alcohol consumption on AMH levels specifically in the African-American populations. In this study, researchers collected information on duration, frequency, amount, and pattern of alcohol and cigarette consumption to better characterize the influence of such common behaviors on AMH levels in reproductive-age African-American women.

Among women who currently drink, high-frequency current binge drinking was associated with lower anti-Müllerian hormone levels. Strengths included investigation of a highly understudied population and assessment of the impact of not only drinking and smoking exposure but also patterns including binge drinking. Limitations included the relatively small sample size of heavy smokers in the study cohort and the use of self-reported data. Future, longitudinal studies that follow changes in anti-Müllerian hormone levels over time would confirm findings and clarify whether the impact of these common lifestyle behaviors enact a transient or permanent impact on ovarian reserve.

Click to read the study in ACOG

RELATED REPORTS

Deficits in executive function are not universal among patients with alcohol use disorder

Few interventions improve posthospitalization follow-up for alcohol use disorder

The Scan by 2 Minute Medicine®: Another Viral Virus, Is One Drink Too Much?, Eggs, Humans, and the Flu, and Detrimental Exercise:

Relevant Reading: Anti-Müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)

In-Depth [cross-sectional study]: Researchers analyzed data collected at the baseline clinical visit of the Study of Environment, Lifestyle and Fibroids, an ongoing prospective cohort study following 1654 23-34 year old African-American women in Detroit, Michigan. Data collection on alcohol intake and cigarette smoking, and serum collection for AMH measurement were performed by computer questionnaire and an in-person clinical visit, respectively. The primary outcome was serum anti-Müllerian hormone level. Potential confounders including age, BMI and hormonal contraception usage were adjusted for in multivariable linear and logistic regressions.

Among reproductive-age African-American women who currently drink alcohol, binge drinking (≥4 drinks/occasion) two or more times per week was associated with 26% lower anti-Müllerian hormone levels (p < 0.04). Most women (74% of all women, n = 1168) drink alcohol, and most drinkers (74%, n = 866) report binge drinking in the last year. The minority of women (19%) currently smoke and just 4% currently consume a pack or more per day. Other alcohol consumption patterns, smoking status, and exposure to secondhand smoke were not significantly associated with anti-Müllerian hormone levels.

Image: CC/Wiki/Narek75

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Alcoholanti-Mullerian hormone (AMH)
Previous Post

Migraines associated with an increased risk of cardiovascular events in women

Next Post

AAP supports mindfulness of children’s media consumption

RelatedReports

Chronic Disease

Deficits in executive function are not universal among patients with alcohol use disorder

September 15, 2026
Chronic Disease

Few interventions improve posthospitalization follow-up for alcohol use disorder

September 14, 2026
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Another Viral Virus, Is One Drink Too Much?, Eggs, Humans, and the Flu, and Detrimental Exercise:

January 21, 2025
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

Certain genetic predispositions may increase risk of atrial fibrillation among those with high alcohol consumption

December 29, 2023
Next Post
Parents desensitized with increasing exposure to movie violence/sex

AAP supports mindfulness of children’s media consumption

High incidence of foreskin morbidity in uncircumcised males

Adolescent bariatric surgery associated with improved mobility and reduced musculoskeletal pain

Publication of pneumonia antibiotic guidelines changed prescribing trends

Buprenorphine implants more likely than sublingual delivery to prevent opioid relapse

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The rate of urethrocutaneous fistula following caudal and penile blocks for hypospadias repair may be similar
  • Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma
  • Deep learning model improved cancer recurrence prediction for pediatric glioma using serial imaging
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.